| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 09/07/1999 | US5948787 Mixture of morphine sulfate and surfactant |
| 09/07/1999 | US5948773 Formulation comprising antibacterial substance and antiulcer substance |
| 09/07/1999 | US5948768 Treatment of otitis media by sublingual administration of DNA |
| 09/07/1999 | US5948767 Transport of active material into cells; drug delivery |
| 09/07/1999 | US5948760 Therapeutic use of superoxide dismutases |
| 09/07/1999 | US5948756 Therapeutic lipoprotein compositions |
| 09/07/1999 | US5948751 X14-mannitol |
| 09/07/1999 | US5948749 Mixture of a divinylbenzene-styrene copolymer powder absorbent and biological active peptide |
| 09/07/1999 | US5948442 Nucleoside, low and high molecular weight peptides, activation of biosynthesis of nucleic aics and specific proteins |
| 09/07/1999 | US5948441 Using a tangential flow filter |
| 09/07/1999 | US5948440 Modified release matrix formulation of cefaclor and cephalexin |
| 09/07/1999 | US5948439 Of herbal medication, an acid, a base capable of releasing carbon dioxide when reacting with acid and water, and sodium lauryl sulfate; for efficient dispersal into bathing water for topical administration or into steam for inhalation |
| 09/07/1999 | US5948438 Oral solid dosage form |
| 09/07/1999 | US5948437 Pharmaceutical compositions using thiazepine |
| 09/07/1999 | US5948436 Protease inhibitor |
| 09/07/1999 | US5948435 Methods of regulating CETP genes, enzymes and other compound, and pharmaceutical composition therefor |
| 09/07/1999 | US5948434 Administering dehydroepiandrosterone or dehydroepiandrosterone sulphate via transdermal patch |
| 09/07/1999 | US5948433 Transdermal patch |
| 09/07/1999 | US5948432 Keratin-based sheet material for biomedical applications and method of production |
| 09/07/1999 | US5948431 Medicated animal foodstuffs |
| 09/07/1999 | US5948430 Water soluble film for oral administration with instant wettability |
| 09/07/1999 | US5948426 Method and article to induce hematopoietic expansion |
| 09/07/1999 | US5948422 Oral dosage-forms containing a β-lactam antibiotic |
| 09/07/1999 | US5948420 Gelled mixture of cationic polymer, hydrophobic ester, propylene or butylene glycol and glycerine |
| 09/07/1999 | US5948416 Stable topical compositions |
| 09/07/1999 | US5948414 Herbal based nasal spray |
| 09/07/1999 | US5948407 Oral induction of tolerance to parenterally administered non-autologous polypeptides |
| 09/07/1999 | US5948401 Cationic therapeutic systems |
| 09/07/1999 | US5948397 Skin care treatment for embalmed bodies |
| 09/07/1999 | US5948389 Method of enhancing the analgesic efficacy of locally and topically administered opioids and other local anesthetics |
| 09/07/1999 | US5948384 Particulate agents |
| 09/07/1999 | US5948020 Implantable bioresorbable membrane and method for the preparation thereof |
| 09/07/1999 | US5947921 Chemical and physical enhancers and ultrasound for transdermal drug delivery |
| 09/07/1999 | CA2007752C Extrudable elastic oral pharmaceutical gel compositions and metered dose dispensers containing them and method of making and method of use thereof |
| 09/07/1999 | CA2005200C Dispersed systems and method of manufacture |
| 09/07/1999 | CA2002363C Sustained release preparations |
| 09/06/1999 | CA2225062A1 Menopause patch |
| 09/05/1999 | CA2261543A1 Anti-cellulite pantyhose |
| 09/02/1999 | WO1999043698A1 Substance having steroid-like structure, process for the production thereof and antitumor agents containing the same |
| 09/02/1999 | WO1999043426A1 Matrix for preparing microparticles or nanoparticles, method for making said particles and resulting particles |
| 09/02/1999 | WO1999043359A1 Nanoparticles comprising polyisobutylcyanoacrylate and cyclodextrins |
| 09/02/1999 | WO1999043355A2 Formulations containing oxaliplatin |
| 09/02/1999 | WO1999043350A1 Use of skin penetration enhancers and barrier disruption agents to enhance the transcutaneous immune response induced by adp-ribosylating exotoxin |
| 09/02/1999 | WO1999043349A1 Mucosal microparticle conjugate vaccine |
| 09/02/1999 | WO1999043343A1 Novel peptide copolymer compositions |
| 09/02/1999 | WO1999043342A1 Somatotropin compositions mixed with vitamins |
| 09/02/1999 | WO1999043340A1 Oral compositions at low dosage of cytotoxic proteins |
| 09/02/1999 | WO1999043334A1 Use of rhamnolipids in wound healing, treating burn shock, atherosclerosis, organ transplants, depression, schizophrenia and cosmetics |
| 09/02/1999 | WO1999043307A1 Thyroid hormone replacement using sustained release triiodothyronine |
| 09/02/1999 | WO1999043306A1 An orally disintegrating composition and its manufacturing method |
| 09/02/1999 | WO1999043305A1 Cross-linked high amylose starch having functional groups as a matrix for the slow release of pharmaceutical agents |
| 09/02/1999 | WO1999043304A1 Stable shaped particles of crystalline organic compounds |
| 09/02/1999 | WO1999043303A1 Method for producing encased spherical granular grains |
| 09/02/1999 | WO1999043302A1 Stabilizing composition for pharmaceutical dosage forms |
| 09/02/1999 | WO1999043301A1 Lipid emulsions in the treatment of systemic poisoning |
| 09/02/1999 | WO1999043300A1 Butorphanol sustained release formulations |
| 09/02/1999 | WO1999043299A2 Oral formulation for hydrophilic drugs |
| 09/02/1999 | WO1999043294A1 Oral care compositions comprising chlorite and methods |
| 09/02/1999 | WO1999043269A2 Veterinary delivery device and method |
| 09/02/1999 | WO1999032158A3 Aminobiguanides to disinfect contact lenses and preserve pharmaceutical compositions |
| 09/02/1999 | WO1999032085A3 Novel pharmaceutical compositions of uridine triphosphate |
| 09/02/1999 | WO1999030693A3 A double capsule for the administration of active principles in multiple therapies |
| 09/02/1999 | WO1999022772A9 LIPOSOMAL OLIGONUCLEOTIDE COMPOSITIONS FOR MODULATING ras GENE EXPRESSION |
| 09/02/1999 | WO1998040052A9 Cationic lipid compositions targeting angiogenic endothelial cells |
| 09/02/1999 | WO1998034632A9 Compounds and compositions for delivering active agents |
| 09/02/1999 | WO1997046205A3 Anti-viral, anhydrous, and mild skin lotions for application to tissue paper products |
| 09/02/1999 | CA2355772A1 Veterinary delivery device and method |
| 09/02/1999 | CA2322175A1 Mucosal microparticle conjugate vaccine |
| 09/02/1999 | CA2321924A1 Butorphanol sustained release formulations |
| 09/02/1999 | CA2321717A1 Oral compositions at low dosage of cytotoxic proteins |
| 09/02/1999 | CA2321528A1 Substance having steroid-like structure, method for preparation therof and antitumor agent containing |
| 09/02/1999 | CA2320289A1 Novel peptide copolymer compositions |
| 09/02/1999 | CA2284838A1 Somatotropin compositions mixed with vitamins |
| 09/01/1999 | EP0938903A1 Ophthalmic composition with regulated viscosity |
| 09/01/1999 | EP0938902A1 Human growth hormone-containing aqueous pharamceutical composition |
| 09/01/1999 | EP0938900A1 Preventives/remedies for stomatitis |
| 09/01/1999 | EP0938896A1 Autoclavable pharmaceutical compositions containing a chelating agent |
| 09/01/1999 | EP0938895A1 New composition to be delivered to the rhinopharyngeal mucose, particularly pernasal |
| 09/01/1999 | EP0938894A1 Implantable radiopaque device and use thereof |
| 09/01/1999 | EP0938893A1 Cell encapsulating device |
| 09/01/1999 | EP0938881A1 Collagen-base auxiliary agent for ophthalmic surgery |
| 09/01/1999 | EP0938657A2 Improvements in detection systems and methods for predicting the dissolution curve of a drug from a pharmaceutical dosage form |
| 09/01/1999 | EP0938580A1 Artificial polymeric membrane structure, method for preparing same, method for preparing this polymer, particle and film containing this structure |
| 09/01/1999 | EP0938549A1 Polymer-protein composites and methods for their preparation and use |
| 09/01/1999 | EP0938467A1 Process for the preparation of optically pure isomers of formoterol |
| 09/01/1999 | EP0938369A2 Emulsifier mixtures and their use for preparing pit emulsions |
| 09/01/1999 | EP0938345A1 Aqueous-based pharmaceutical composition |
| 09/01/1999 | EP0938343A2 Tumor delivery vehicles and method to enhance treatment of cystic tumors |
| 09/01/1999 | EP0938342A2 Injection implant |
| 09/01/1999 | EP0938341A2 Compositions and methods for altering the biodistribution of biological agents |
| 09/01/1999 | EP0938331A1 Therapeutic uses of bpi protein products in cystic fibrosis patients |
| 09/01/1999 | EP0938325A1 Methods for sterilizing male mammals |
| 09/01/1999 | EP0938318A1 Tablet with controlled release of alfuzosine chlorydrate |
| 09/01/1999 | EP0938316A2 Galenic composition containing opioid antagonists |
| 09/01/1999 | EP0938302A1 Pleasant-tasting aqueous liquid composition of a bitter-tasting drug |
| 09/01/1999 | EP0938301A1 Directly compressible lactitol and method |
| 09/01/1999 | EP0938300A2 Substituted amylose as a matrix for sustained drug release |
| 09/01/1999 | EP0938299A1 Methods for the production of protein particles useful for delivery of pharmacological agents |
| 09/01/1999 | EP0938298A1 Liposomes |
| 09/01/1999 | EP0938297A1 Immunomodulatory formulation |